Paul R Kirchgraber Laboratory Corp Of America Holdings (LH) insider trading activity
Paul R Kirchgraber is CEO, Covance Drug Development of LABORATORY CORP OF AMERICA HOLDINGS. Currently has a direct ownership of 12,946 shares of LH, which is worth approximately $2.96 Million. The most recent transaction as insider was on Apr 03, 2021, when has been sold 452 shares (Common Stock) at a price of $252.67 per share, resulting in proceeds of $114,207. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
12.9K
0%
3M change
0%
12M change
Total Value Held
$2.96 Million
Paul R Kirchgraber Transaction History
PRK
Paul R Kirchgraber
CEO, Covance Drug Development
Burlington, NC